Nitric Acid

Nitric Acid

SCHEMBL3858360

Cc1cc([N+](=O)[O-])ccc1NC(=N)N.O=[N+]([O-])O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 2/20 0.60
GRIN3B O60391 2/20 0.60
GRIN1 Q05586 2/20 0.60
GRIN2A Q12879 2/20 0.60
GRIN2B Q13224 2/20 0.60
GRIN2C Q14957 2/20 0.60
GRIN3A Q8TCU5 2/20 0.60
SIGMAR1 Q99720 2/20 0.60
ALDH1A1 P00352 6/20 0.59
HTT P42858 4/20 0.56
MAPT P10636 4/20 0.53
LMNA P02545 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MAPK1 P28482 1/20 0.52
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11876436 0.97 GRIN2D (0.63) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Nitric Acid SCHEMBL30496141 0.88 HTT (0.57) ALDH1A1HTTMAPTLMNAMEN1
Nitric Acid SCHEMBL1717 0.88 HTT (0.57) ALDH1A1HTTMAPTLMNAMEN1
SCHEMBL30078131 0.85 HTT (0.59) ALDH1A1HTTMAPTLMNAMEN1
SCHEMBL1583292 0.85 HTT (0.59) ALDH1A1HTTMAPTLMNAMEN1
Hydrochloric Acid SCHEMBL2930759 0.84 HTT (0.58) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5520652 0.83 MAPT (0.64) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Nitric Acid SCHEMBL3635730 0.82 CYP3A4 (0.61) ALDH1A1HTTMAPTLMNAMEN1
SCHEMBL5532892 0.82 ALDH1A1 (0.71) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL11263800 0.82 HTT (0.59) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595323-B2 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof IL YANG PHARM. CO., LTD. (KR) 2009-09-29 US disclosed
US-20040248918-A1 Anticancer agents IL YANG PHARM. CO., LTD. 2004-12-09 US disclosed
WO-2004099187-A1 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF IL YANG PHARM. CO. LTD. (KR) 2004-11-18 WO disclosed
WO-2004099186-A1 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF IL YANG PHARM CO., LTD. (KR) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248918-A1 Anticancer agents BRDT, CHIA, RNASE1 GRIN2D 3654/4885GRIN3B 2330/4885GRIN1 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.